Rich,
I am new here and saw your post. I don't know where you are located, but Memorial Sloan-Kettering is doing a Phase II feasibility trial of AC and Taxol with Herceptin. It is a small trial of only 70 individuals of dose-dense AC once every 2 weeks for four cycles and then Taxol once every 2 weeks for four cycles, followed by Herceptin once a week or even possibly once every three weeks. It is the only clinical trial available combining dose-dense chemo with the Herceptin. It is not randomized. All patients will receive the same therapy and will be closely monitored for any signs of cardiotoxicity. It is for early stage breast cancer node positive or high-risk node negative. You can find out more about the trial on
www.MSKCC.org and look under find a clinical trial. The trial coordinators are Dr. Dang and Dr. Hudis. I was hoping to participate in the trial, but Sloan is not a participating provider for my insurance company.
Kim